Equity News
Is Acadia Pharmaceuticals Inc. (ACAD) Stock Entering in Growth Territory?
The pharmaceutical firm Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) had its stock rise 15.51 percent to $18.77 in trade on June 15, thanks to the release of official statistics. The US Food and Medicine Administration (FDA) has released data that might imply that the findings of
